BURDEN OF EARLY-ONSET NEONATAL SEPSIS IN THE RUSSIAN FEDERATION
Author(s)
Soldatova I1, Pankratyeva L2, Avxentyeva M3, Omelyanovsky V11Research Center for Clinical and Economic Evaluation and Pharmacoeconomics, Russian National Research Medical University, Moscow, Russia, 2Russian National Research Medical University, Moscow, Russia, 3National Center for Technology Assessment in Health Care, Moscow, Russia
The economic burden of early-onset neonatal sepsis (EONS) is currently uncertain in Russia. OBJECTIVES: To evaluate economic burden of EONS and mortality in the Russian Federation, including both direct and indirect costs. METHODS: Chosen methodology was based on the analysis of the sample of medical records from neonatal intensive care units (NICUs). Neonates (n=79) were classified according to gestational age (GA). Direct costs were calculated based on the data about resource consumption in real prectice. Indirect costs included underproduced contribution to GDP due to premature death and morbidity, resulting from disease, welfare and care payments, comprising disability support pensions. RESULTS: Mean cost of hospitalization to NICU (direct costs) per infant with EONS is estimated as € 9,092. Mean direct costs for hospitalization per extremely-low-birth-weight (ELBW) infant are twice higher in comparison with mean direct costs per infant with GA ≥30 weeks of gestation (€ 21,056 per ELBW infant and € 11,938 per infant with GA ≥30 weeks of gestation). Total underproduced contribution to GDP is estimated as € 152,254 (87% of total costs) per infant with EONS, welfare and care payments, comprising disability support pensions - € 14,721 (8%) per infant. Thus indirect costs account for 95% of expenditure. Total costs associated with EONS are estimated as € 176,067 per infant. CONCLUSIONS: Improvement of treatment of EONS may play the crucial socio-economic role since it could significantly reduce the economic burden of the disease for the Russian Federation.
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
PIH12
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Infectious Disease (non-vaccine), Pediatrics